<DOC>
	<DOCNO>NCT01109784</DOCNO>
	<brief_summary>The use dual antiplatelet therapy consider standard care patient post percutaneous coronary intervention ( PCI ) stenting . However , significant proportion patient consider clopidogrel resistant resistance show accompanied future adverse event . Additionally , clopidogrel resistance link CYP2C19 polymorphism . The hypothesis study define consecutive patient undergo PCI clopidogrel resistant PCI follow routinely use loading estimate predischarge VerifyNow point care system platelet reactivity . Clopidogrel resistant patient randomize 1:1 fashion prasugrel 10 mg clopidogrel 150mg daily . Platelet reactivity assess day 30 , treatment crossover perform . At day 60 platelet reactivity determine well . In addition , patient genetic determination CYP polymorphism ( include CYP2C19 ) know affect clopidogrel metabolism perform .</brief_summary>
	<brief_title>Prasugrel Versus High Dose Clopidogrel Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention ( PCI ) .</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>Age ≥18 year old Patients PCI stenting 2448 hour prior randomization , 1 . Stable angina 2.Ischaemia provocative test 3.Acute coronary syndrome ( unstable angina myocardial infarction ) Written Informed consent Platelet reactivity unit ( PRU ) ( VerifyNow ) &gt; 230 A history bleed diathesis Chronic oral anticoagulation treatment Contraindications antiplatelet therapy Known platelet function disorder PCI coronary artery bypass surgery &lt; 3 month Unsuccessful PCI ( residual stenosis &gt; 30 % flow &lt; Thrombolysis myocardial infarction flow 3 ) Planned stag PCI next 60 day Hemodynamic instability Cancer hemodialysis Platelet count &lt; 100 000/ μL , hematocrit &lt; 30 % Creatinine clearance &lt; 25 ml/min A life expectancy &lt; 1 year , inability give inform consent High likelihood unavailable Day 60 follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>coronary angioplasty</keyword>
	<keyword>clopidogrel resistance</keyword>
	<keyword>prasugrel</keyword>
</DOC>